Placebo, nocebo, and neuropathic pain [PDF]
Pain, 2016 Over the last decade, the apparent increase in placebo responses in randomized controlled trials (RCTs) of neuropathic pain have complicated and potentially limited development and availability of new effective pain medication. Placebo analgesia and nocebo hyperalgesia effects are well described in nociceptive and idiopathic pain conditions, but less ...
Vase, Lene; Skyt, Ina; Hall, Kathryn T.
openaire +3 more sources
Development and Validation of the Brief Inventory of Treatment Expectations in Chronic Pain (BITEC)
European Journal of Pain, Volume 30, Issue 2, February 2026.ABSTRACT Background Expectations shape therapeutic outcomes, yet their systematic assessment remains limited in clinical and research settings. To address this gap, we developed and validated the Brief Instrument for the Assessment of Treatment Expectations in Chronic Pain (BITEC) using Item Response Theory. Methods The study comprised four phases. (I)
Wolnei Caumo +8 more
wiley +1 more source
Journal of Education and Health Promotion, 2023 BACKGROUND: Psychological distress and perceived stress may complicate the clinical presentation, course, and treatment of patients with functional gastrointestinal disorders.
Hamid Nasiri-Dehsorkhi +3 more
doaj +1 more source
The placebo and nocebo effects on peak minute power during incremental arm crank ergometry [PDF]
, 2013 This is an Accepted Manuscript of an article published by Taylor & Francis Group in European Journal of Sport Science on 19 May 2014, available online: http://www.tandfonline.com/doi/abs/10.1080/17461391.2013.822564.This investigation aimed to explore ...
Andrew Nicholettos +6 more
core +2 more sources
AB1615 EVALUATION OF THE NOCEBO EFFECT WHEN SWITCHING FROM THE ORIGINATOR MOLECULE TO A BIOSIMILAR IN A NORMANDY RETROSPECTIVE COHORT OF PATIENTS WITH INFLAMMATORY RHEUMATISM TREATED WITH ETANERCEPT OR ADALIMUMAB (BIONORIC STUDY) [PDF]
, 2023 O. Hagege +8 more
openalex +1 more source
Arthritis Care &Research, Volume 78, Issue 1, Page 31-37, January 2026.Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen +4 more
wiley +1 more source
Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial [PDF]
, 2022 Twyla Michnevich +5 more
openalex +1 more source
Clinical Psychology &Psychotherapy, Volume 33, Issue 1, January/February 2026.ABSTRACT Steven J. Lynn (1946–2024) was a prolific researcher who explored a wide array of topics in clinical psychology. He and his co‐authors emphasized the importance of researching the side effects of psychological interventions. In the current studies (Study 1, N = 58; Study 2, N = 64), we examined clinicians' perspectives on side effects.
Sanne T. L. Houben +3 more
wiley +1 more source
Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses. [PDF]
PLoS ONE, 2014 A large number of unwanted adverse events and symptoms reported by patients in clinical trials are not caused by the drug provided, since most of adverse events also occur in corresponding placebo groups.
Laura Wendt +8 more
doaj +1 more source
Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent—Evidence from dynamometry [PDF]
, 2022 Nina Zech +2 more
openalex +1 more source